Table 1 Descriptive statistics of the study sample
From: Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age
| Â | Early relapse | Late relapse | p |
|---|---|---|---|
N, n (%) | 17 (48.6) | 18 (51.4) | – |
Female, n (%) | 6 (35.3) | 4 (22.2) | 0.458 |
Age at diagnosis, mean (SD), years | 55.4 (10.1) | 55.8 (8.9) | 0.882 |
Time to first treatment, mean (SD), years | 2.1 (3.3) | 2.0 (1.3) | 0.875 |
Time to relapse, mean (SD), years | 1.5 (0.5) | 5.2 (2.1) | < 0.001 |
IEAA, mean (SD), years | − 1.6 (17.6) | 1.5 (13.8) | 0.573 |
EEAA, mean (SD), years | 6.8 (17.8) | − 6.4 (18.0) | 0.036 |
PhenoAA, mean (SD), years | 2.3 (16.7) | − 2.2 (22.1) | 0.507 |
GrimAA, mean (SD), years | − 3.2 (6.0) | 3.1 (5.2) | 0.002 |